Emotra AB (“Emotra” or “the Company”) has completed the Rights Issue of units decided by the Board on April 22, 2021... 20210617 - Emotra- PM - Freferential share issue for underwriters
In the fully underwritten rights issue in Emotra AB (“Emotra” or “the Company”) amounting to appr. 9.5 MSEK... 20210615 - Emotra- PM - Rights issue outcome
After a period of discussions, an agreement for collaboration has been signed between National Institute of Mental Health (NIMH) in USA and Emotra. 210609 - Emotra - PM - Emotra signs agreement with NIMH
Vid årsstämma i Emotra AB (publ) (”Emotra” eller Bolaget”) idag den 24 maj 2021 i Göteborg beslutades bland annat följande. 210524 - Emotra - PM - Kommuniké Årsstämma
Emotra AB (publ) (”Emotra”) meddelar idag att bolagets årsredovisning avseende räkenskapsåret 2020 och övriga handlingar... 210429 - Emotra- PM - Årsredovisning 2020 och handlingar inför stämman
At this year’s regular shareholder meeting, Emotra AB (“Emotra” or “the Company”) will propose the nomination of Ingela Hallberg as a new director. 210422 - Emotra- PM - Board changes
After a period of negotiations between Emotra and the Japanese company Beauty Life Corporation (BLC), the two companies have signed a letter of intent. 210415 - Emotra - PM - Emotra signs Letter Of Intent with BLC
Efter en tids diskussioner mellan Emotra och det japanska bolaget Beauty Life Corporation (BLC) har nu en avsiktsförklaring, så kallat Letter Of Intent, tecknats. 210415 - Emotra - PM - Emotra signerar avsiktsförklaring med BLC
The Board and CEO of Emotra AB herewith present the year-end report for the financial year 2020. 210224 Year-end report 2020 EN
An article on the first study on the connection between hyporeactivity and increased risk of depression relapse has been published... 210215 - Emotra- PM - Publication in BMC Psychiatry
